Robert E Claypoole
President and CEO, Director at Bioventus Inc. (BVS) since January 2024
Robert E Claypoole has filed 6 insider reports with the SEC since January 2024, as president and CEO and director at Bioventus Inc. (BVS). Robert E Claypoole made no open-market purchases or sales in the last 12 months. The latest filing, on March 17, 2026, reports grant or award, shares withheld for taxes or exercise price and exercise or conversion of a derivative at Bioventus Inc. (BVS).
- Filings
- 6
- Companies
- 1
- Bought on market
- None
- Sold on market
- $262K
Companies where Robert E Claypoole is an insider
| Company | Role | Shares held | Bought | Sold | Avg buy | Price now | Last filing |
|---|---|---|---|---|---|---|---|
| President and CEO, Directorsince January 2024 | 135,944 | $262K | $9.88 | Mar 17, 2026 |
Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record.
Every filing
- Mar 13, 2026BVSPresident and CEO Claypoole Robert E converted options into 33,500 shares and covered exercise/tax liability with 14,553 shares, increasing direct ownership by 16% to 135,944 unitsForm 4Grant or awardShares withheld for taxes or exercise priceExercise or conversion of a derivative
- Jan 9, 2026BVSPresident and CEO Claypoole Robert E covered exercise/tax liability with 41,717 shares and converted options into 93,750 shares, increasing direct ownership by 80% to 116,997 unitsForm 4Shares withheld for taxes or exercise priceExercise or conversion of a derivative
- Jan 13, 2025-$262KBVSPresident and CEO Claypoole Robert E sold $261,953 worth of shares (28,786 units at $9.10), decreasing direct ownership by 31% to 64,964 unitsForm 4Open-market sale10b5-1 plan
- Jan 10, 2025BVSPresident and CEO Claypoole Robert E converted options into 93,750 sharesForm 4Exercise or conversion of a derivative
- Jan 11, 2024BVSSEC Form 4 filed by Claypoole Robert EForm 4Grant or award
- Jan 10, 2024BVSNew insider Claypoole Robert E claimed no ownership of stock in the companyForm 3New insider
Compare Robert E Claypoole with
- Robert E Claypoole vs John A. Bartholdson1 shared
- Robert E Claypoole vs Martin P Sutter1 shared
- Robert E Claypoole vs Susan M Stalnecker1 shared
- Robert E Claypoole vs Guy P Nohra1 shared
- Robert E Claypoole vs Guido J Neels1 shared
- Robert E Claypoole vs Mary Kay Ladone1 shared
Other insiders at the same companies
- John A. BartholdsonBVS
- Martin P SutterBVS
- Susan M StalneckerBVS
- Guy P NohraBVS
- Guido J NeelsBVS
- William A HawkinsBVS
- Mary Kay LadoneBVS
- Michelle McMurry-HeathBVS
- Philip G. CowdyBVS
- Pat BeyerBVS
- Mark Leonard SingletonBVS
- Katrina J ChurchBVS
- Anthony D'AdamioBVS
- Ajay DhankharBVS
Questions about Robert E Claypoole
- What is Robert E Claypoole's role at Bioventus Inc.?
- Robert E Claypoole reports to the SEC as president and CEO and director at Bioventus Inc. (BVS), according to the latest filing on March 17, 2026.
- How many shares does Robert E Claypoole own?
- After the latest filing that states it, Robert E Claypoole directly owned 135,944 shares of Bioventus Inc. (BVS). Shares held through trusts, funds or family members are reported separately and are not counted here.
- Has Robert E Claypoole bought or sold stock recently?
- The most recent open-market sale was on January 13, 2025: sold 28,786 shares of Bioventus Inc. (BVS) for $262K at an average of $9.10.
- How do I get alerts when Robert E Claypoole files?
- Follow Robert E Claypoole on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale.
From SEC Forms 3, 4, 5 and 144 filed by Robert E Claypoole (SEC CIK 0002005474). Totals count each trade once, skipping amendments whose original is on file, from Jan 12, 2024 on. View on SEC EDGAR · Get this as JSON